CA2714880C - Nouveau biomarqueur de tumeur - Google Patents
Nouveau biomarqueur de tumeur Download PDFInfo
- Publication number
- CA2714880C CA2714880C CA2714880A CA2714880A CA2714880C CA 2714880 C CA2714880 C CA 2714880C CA 2714880 A CA2714880 A CA 2714880A CA 2714880 A CA2714880 A CA 2714880A CA 2714880 C CA2714880 C CA 2714880C
- Authority
- CA
- Canada
- Prior art keywords
- hsp90a
- cancer
- polypeptide
- plasma
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La présente invention concerne le diagnostic et le traitement du cancer, plus particulièrement un procédé de diagnostic de la présence ou dune métastase dun cancer par détection de plasma Hsp90.alpha. ayant une séquence dacides aminés de SEQ ID NO. 1 comme marqueur de tumeur. En outre, la présente invention concerne également un procédé pour le traitement du cancer et dune métastase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2714880A CA2714880C (fr) | 2010-09-15 | 2010-09-15 | Nouveau biomarqueur de tumeur |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2714880A CA2714880C (fr) | 2010-09-15 | 2010-09-15 | Nouveau biomarqueur de tumeur |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2714880A1 CA2714880A1 (fr) | 2012-03-15 |
CA2714880C true CA2714880C (fr) | 2018-11-20 |
Family
ID=45816187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2714880A Active CA2714880C (fr) | 2010-09-15 | 2010-09-15 | Nouveau biomarqueur de tumeur |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2714880C (fr) |
-
2010
- 2010-09-15 CA CA2714880A patent/CA2714880C/fr active Active
Also Published As
Publication number | Publication date |
---|---|
CA2714880A1 (fr) | 2012-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101587932B1 (ko) | 네트린-1 활성을 이용한 항암 화합물의 스크리닝 | |
AU2010268979B2 (en) | New tumor marker | |
CN107098970B (zh) | 结合细胞内prl-1多肽或prl-3多肽的抗体 | |
KR20140107615A (ko) | 엑소좀 검출용 모노클로날 항체 | |
DK2743697T3 (en) | METHODS OF IN VITRO DIAGNOSTICS OF INVASIVE CARCINOMS | |
Jiang et al. | Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients | |
WO2013142965A1 (fr) | Variantes du domaine sh2 | |
WO2008115300A1 (fr) | Phosphorylation de c-kit dans les cas de cancer | |
US9815906B2 (en) | Method of inhibiting or treating cancer metastasis | |
CN103694332B (zh) | 一种新的肿瘤标志物 | |
US8232069B2 (en) | Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes | |
KR102429562B1 (ko) | 간세포암 진단용 바이오마커 세레브론 및 이에 특이적인 신규한 단일클론항체 | |
JP2010151800A (ja) | 生活習慣病及び/又は癌の診断剤 | |
JP2022180377A (ja) | 受容体タンパク質を標的とする治療薬、検査薬、受容体タンパク質に結合する抗体、及び分子標的薬のスクリーニング方法 | |
CA2714880C (fr) | Nouveau biomarqueur de tumeur | |
AU2014203702B2 (en) | New tumor marker | |
CN113398270B (zh) | 一种治疗骨巨细胞瘤的方法 | |
JP2008031063A (ja) | 癌抑制剤 | |
WO2018034332A1 (fr) | ANTICORPS FRAGMENT DE L'EXTRÉMITÉ N-TERMINALE EphA2 | |
WO2012133994A1 (fr) | Procédé de dépistage destiné à un agent de traitement du cancer utilisant une interaction entre le pauf et l'un de ses partenaires de liaison | |
WO2007037532A9 (fr) | Application therapeutique ou diagnostique du gene srms | |
WO2007037533A9 (fr) | Application therapeutique ou diagnostique du gene ppp1r3d |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20150401 |